US Patent 11007167 Methods of treating multiple sclerosis
Patent 11007167 was granted and assigned to Biogen on May, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
October 15, 2020
Date of Patent
May 18, 2021
Patent Applicant
Patent Application Number
17071740
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11007167 Methods of treating multiple sclerosis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
